Trials / Completed
CompletedNCT02304770
Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia
A Pilot Study of Aminolaevulinic Acid (ALA) Photodynamic Therapy (PDT) in Patients With Cervical Persistent High Risk HPV Infection or Cervical Intraepithelial Neoplasia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · Industry
- Sex
- Female
- Age
- 25 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The study will examine the effect of aminolaevulinic acid (ALA) photodynamic therapy (PDT) of cervical precancerous lesions in women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aminolaevulinic acid photodynamic therapy | Aminolaevulinic acid mediated photodynamic therapy |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2014-12-02
- Last updated
- 2019-06-12
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02304770. Inclusion in this directory is not an endorsement.